Skip to main content
Top
Published in: World Journal of Surgery 9/2010

01-09-2010

Effect of Pancreaticoduodenectomy on the Course of Hepatic Steatosis

Authors: Hsin-Hsien Yu, Yan-Shen Shan, Pin-Wen Lin

Published in: World Journal of Surgery | Issue 9/2010

Login to get access

Abstract

Background

The progression of hepatic steatosis after pancreaticoduodenectomy (PD) is controversial. This study was designed to determine whether PD would influence the course of hepatic steatosis.

Methods

Patients admitted for PD and distal pancreatectomy (DP) from January 2004 to January 2008 were enrolled. Exclusion criteria included liver metastasis, severe obesity (body mass index >30), diabetic mellitus, excessive alcohol consumption, and unavailable preoperative and 6-month postoperative unenhanced CT images. The pre-PD and post-PD liver attenuation, ratio, and difference of liver-to-spleen attenuation between liver and spleen attenuation were compared.

Results

Fifty patients who underwent PD and 20 patients who underwent DP were eligible. The mean follow-up period was 18.2 ± 1.6 months for the PD group and 19.7 ± 1.7 months for the DP group. Liver attenuation after PD was significantly decreased from 52.3 ± 1.1 H. to 47.6 ± 2 H. (p = 0.044), but no difference was observed in spleen attenuation. The liver-to-spleen attenuation ratio after PD also was significantly decreased: 1.12 ± 0.02 versus 1.01 ± 0.04 (p = 0.033). No difference in liver attenuation was found in the DP group. The female gender was a significant risk factor.

Conclusions

The liver attenuation of CT images decreases in patients who receive PD, which implicates that hepatic steatosis can develop after PD; however, the mechanism needs to be elucidated.
Literature
1.
go back to reference Huang JJ, Yeo CJ, Sohn TA et al (2000) Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231:890–898CrossRefPubMed Huang JJ, Yeo CJ, Sohn TA et al (2000) Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231:890–898CrossRefPubMed
2.
go back to reference Armstrong T, Walters E, Varshney S et al (2002) Deficiency of micronutrients, altered bowel function, and quality of life during late follow-up after pancreaticoduodenectomy for malignancy. Pancreatology 2:528–534CrossRefPubMed Armstrong T, Walters E, Varshney S et al (2002) Deficiency of micronutrients, altered bowel function, and quality of life during late follow-up after pancreaticoduodenectomy for malignancy. Pancreatology 2:528–534CrossRefPubMed
3.
go back to reference McLeod RS, Taylor BR, O’Connor BI et al (1995) Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 169:179–185CrossRefPubMed McLeod RS, Taylor BR, O’Connor BI et al (1995) Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 169:179–185CrossRefPubMed
4.
go back to reference Nomura R, Ishizaki Y, Suzuki K et al (2007) Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol 189:1484–1488CrossRefPubMed Nomura R, Ishizaki Y, Suzuki K et al (2007) Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol 189:1484–1488CrossRefPubMed
5.
go back to reference Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312CrossRefPubMed Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312CrossRefPubMed
6.
go back to reference Karcaaltincaba M, Akhan O (2007) Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 61:33–43CrossRefPubMed Karcaaltincaba M, Akhan O (2007) Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 61:33–43CrossRefPubMed
7.
go back to reference Thampanitchawong P, Piratvisuth T (1999) Liver biopsy: complications and risk factors. World J Gastroenterol 5:301–304PubMed Thampanitchawong P, Piratvisuth T (1999) Liver biopsy: complications and risk factors. World J Gastroenterol 5:301–304PubMed
8.
go back to reference Slezak LA, Anderson DK (2001) Pancreatic resection: effects on glucose metabolism. World J Surg 25:452–460CrossRefPubMed Slezak LA, Anderson DK (2001) Pancreatic resection: effects on glucose metabolism. World J Surg 25:452–460CrossRefPubMed
9.
go back to reference Kitamura T, Anaguchi-Hirao R, Kouhara H (2008) Combination of type 2 diabetes and malnutrition worsened by anastomotic stenosis and pancreas atrophy following resection of pancreas head. Intern Med 47:1225–1230CrossRefPubMed Kitamura T, Anaguchi-Hirao R, Kouhara H (2008) Combination of type 2 diabetes and malnutrition worsened by anastomotic stenosis and pancreas atrophy following resection of pancreas head. Intern Med 47:1225–1230CrossRefPubMed
10.
go back to reference Moxley RT III, Pozefsky T, Lockwood DH (1974) Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl J Med 290:921–926CrossRefPubMed Moxley RT III, Pozefsky T, Lockwood DH (1974) Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl J Med 290:921–926CrossRefPubMed
11.
go back to reference McCullough AJ (2006) Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 40:S17–S29PubMed McCullough AJ (2006) Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 40:S17–S29PubMed
12.
go back to reference Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147–152PubMed Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147–152PubMed
13.
go back to reference Utzschneider KM, Kahn SE (2006) The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91:4753–4761CrossRefPubMed Utzschneider KM, Kahn SE (2006) The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91:4753–4761CrossRefPubMed
14.
go back to reference Rubino F, Forgione A, Cummings DE et al (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741–749CrossRefPubMed Rubino F, Forgione A, Cummings DE et al (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741–749CrossRefPubMed
15.
go back to reference Ota T, Takamura T, Kurita S et al (2007) Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132:282–293CrossRefPubMed Ota T, Takamura T, Kurita S et al (2007) Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132:282–293CrossRefPubMed
16.
go back to reference Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastasis. Br J Surg 94:274–286CrossRefPubMed Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastasis. Br J Surg 94:274–286CrossRefPubMed
17.
go back to reference Kato H, Isaji S, Azumi Y et al (2009) Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Surg, Oct 7 [Epub ahead of print] Kato H, Isaji S, Azumi Y et al (2009) Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Surg, Oct 7 [Epub ahead of print]
18.
go back to reference Tobari M, Hashimoto E, Yatsuji S et al (2009) Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med 48:739–746CrossRefPubMed Tobari M, Hashimoto E, Yatsuji S et al (2009) Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med 48:739–746CrossRefPubMed
19.
go back to reference Qayyum A, Chen DM, Breiman RS et al (2009) Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 33:110–115CrossRefPubMed Qayyum A, Chen DM, Breiman RS et al (2009) Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 33:110–115CrossRefPubMed
20.
go back to reference Zhong L, Chen JJ, Chen J et al (2009) Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. J Dig Dis 10:315–320CrossRefPubMed Zhong L, Chen JJ, Chen J et al (2009) Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. J Dig Dis 10:315–320CrossRefPubMed
Metadata
Title
Effect of Pancreaticoduodenectomy on the Course of Hepatic Steatosis
Authors
Hsin-Hsien Yu
Yan-Shen Shan
Pin-Wen Lin
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 9/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0636-8

Other articles of this Issue 9/2010

World Journal of Surgery 9/2010 Go to the issue